KARA BURKHARDT: Open Payments
NPI 1629316807 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 25 payments from 16 companies in 2025. Trend: 2023 $47 · 2024 $73 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $166 |
| Astellas Pharma US Inc | 2 | $44 |
| Hologic Sales and Service, LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $35 |
| Amgen Inc. | 1 | $34 |
| Organon LLC | 1 | $30 |
| SANOFI PASTEUR INC. | 1 | $28 |
| Exact Sciences Corporation | 1 | $26 |
| PFIZER INC. | 1 | $24 |
Products named: VRAYLAR, QULIPTA, Veozah, THINPREP 2000 PROCESSOR, SHINGRIX, CAPLYTA, KRYSTEXXA, NEXPLANON.
Industry payments across CO — which companies pay providers there.
